Created with Sketch.
31 minutes | Jul 28, 2021
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR
In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transforming cancer research.
37 minutes | Jun 14, 2021
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling
The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at the NIH, talk about the inception of the iNDI project, the challenges and opportunities, and the future of neurodegenerative research.
20 minutes | May 26, 2021
Joe Miano Talks About Prime Editing in Mice
Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at the Augusta University in Georgia, talks about their collaborative work comparing traditional CRISPR-mediated homology-directed repair with prime editing in mice.
27 minutes | Apr 28, 2021
IGI Researchers Are Using CRISPR to Reduce Cyanide in Cassava
Did you know cassava can cause cyanide poisoning if it is not processed correctly and consumed with a protein-poor diet? In this episode, we chat with IGI researchers, Jess Lyons and Michael Gomez about their work on using CRISPR to reduce cyanide in cassava and improve its food safety.
32 minutes | Mar 30, 2021
Kevin Davies Chats About His Latest Book "Editing Humanity"
Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing." In this episode, Kevin discusses his motivation for the book, along with some behind-the-scenes stories when writing this timely literature piece.
19 minutes | Feb 24, 2021
Michael Friend Advocates For Diversity in CRISPR
In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists.
18 minutes | Jan 12, 2021
CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans
In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021.
36 minutes | May 20, 2020
CRISPR Office Hours with Hamid Ghanadaan
The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scientists.
13 minutes | May 7, 2020
Ryan Pawell Talks About Indee Labs’ CRISPR Delivery Technology for Affordable Immunotherapies
The mission of Indee Labs, a Berkeley biotech, is to deliver CRISPR reagents into cells using microfluidics for developing affordable cell and gene therapies in the future. We interviewed Ryan Pawell, Founder and CEO of Indee Labs, about the concept of using microfluidics for CRISPR delivery, their mission and ongoing projects, and the convergence of engineering and biology for building scalable platforms.
38 minutes | Apr 23, 2020
Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature
What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film.
10 minutes | Jan 28, 2020
Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller
Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this podcast episode.
13 minutes | Nov 13, 2019
The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes
Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling.
18 minutes | Sep 4, 2019
CRISPR in Fungi: An Interview with Rebecca Shapiro
Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interactions and developing ways for treating fungal biofilms.
22 minutes | Aug 7, 2019
Paul Dabrowski Gets Candid About the Past, Present, and Future of Synthego
In this interview, Paul Dabrowski, CEO of Synthego, talks about how Synthego got started, his mantra behind leading the company, and future directions. He also offers insights into Synthego’s unique capabilities—the powerful combination of engineering and biology that enable scaling.
16 minutes | May 22, 2019
Dana Foss is Solving the CRISPR Delivery Problem to Advance Therapeutics
CRISPR has great potential in therapeutics, but CRISPR delivery in vivo remains a challenge. Researcher Dana Foss discusses her lab’s novel approach for specific delivery of CRISPR components in cells and tissues.
21 minutes | May 8, 2019
SHERLOCK Founders Crack the Case of CRISPR Diagnostics
CRISPR is going beyond gene editing into a new area: diagnostics. Omar Abudayyeh and Jonathan Gootenberg, co-founders of SHERLOCK Biosciences, talk about the present advances and future of CRISPR diagnostics.
19 minutes | Apr 18, 2019
Kiana Aran Chats About Her New Biosensor: CRISPR-Chip
Kiana Aran, a biomedical engineering expert, talks about her research on CRISPR-Chip, a new biosensor that combines CRISPR & electronics to detect specific genes in genomic DNA.
24 minutes | Mar 19, 2019
How the Innovative Genomics Institute is Helping People Understand CRISPR
Megan Hochstrasser, Science Communications Manager at the Innovative Genomics Institute, talks about the importance of CRISPR science communication and the ongoing efforts at IGI to help people understand this genome engineering tool.
28 minutes | Feb 26, 2019
Improving Targeted Delivery to Enhance Personalized Medicine
Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public.
28 minutes | Feb 7, 2019
Alex Philippidis Reviews Trends in Biopharma & Biotech Market
Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise more money and the world changes around them.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021